Differential effects of ibogaine on behavioural and dopamine sensitization to cocaine

European Journal of Pharmacology

Volumn 398, Issue 2, 2000, Pages 259-262

  Szumlinski, Karen K ^a   Maisonneuve, Isabelle M ^a   Glick, Stanley D ^a  

^a ALBANY MEDICAL COLLEGE   (United States)

Author keywords

Cocaine; Dopamine; Drug addiction; Ibogaine; Sensitization; Stereotypy

Indexed keywords

3,4 DIHYDROXYPHENYLACETIC ACID; COCAINE; DOPAMINE; HOMOVANILLIC ACID; IBOGAINE;

ADAPTATION; ADDICTION; ANIMAL EXPERIMENT; ARTICLE; BEHAVIOR; CONTROLLED STUDY; DOPAMINE BRAIN LEVEL; DRUG POTENTIATION; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; LOCOMOTION; MICRODIALYSIS; NONHUMAN; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; RAT; SENSITIZATION; STEREOTYPY;

3,4-DIHYDROXYPHENYLACETIC ACID; ANIMALS; BEHAVIOR, ANIMAL; CATECHOLAMINES; COCAINE; DOPAMINE; FEMALE; HOMOVANILLIC ACID; IBOGAINE; NUCLEUS ACCUMBENS; RATS; RATS, SPRAGUE-DAWLEY; STEREOTYPED BEHAVIOR;

EID: 0034674363     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(00)00325-3     Document Type: Article

References (23)

1. Cadoni C., Di Chiara G. Reciprocal changes in dopamine responsiveness in the nucleus accumbens shell and core and in the dorsal caudate-putamen in rats sensitized to morphine. Neuroscience. 90:1999;447-455.
2. Cadoni C., Di Chiara G. Differential changes in accumbens shell and core dopamine in behavioral sensitization to nicotine. Eur. J. Pharmacol. 387:1999;R23-R25.
3. Cadoni C., Solinas M., Di Chiara G. Psychostimulant sensitization: differential changes in accumbal shell and core dopamine. Eur. J. Pharmacol. 388:2000;69-76.
4. Di Chiara G. Drug addiction as dopamine-dependent associative-learning disorder. Eur. J. Pharmacol. 375:1999;13-30.
5. Frenken G. From the roots up: ibogaine and addict self-help. Alper K.R., Glick S.D. The Alkaloids. Ibogaine: Proceedings of an Interdisciplinary Conference. 2000;Academic Press, New York. in press.
6. Glick S.D., Maisonneuve I.M. Mechanisms of the antiaddictive actions of ibogaine. Ann. N. Y. Acad. Sci. 844:1998;214-226.
7. Glick S.D., Maisonneuve I.M., Szumlinski K.K. Mechanisms of action of ibogaine: relevance to putative therapeutic effects and development of a safer iboga alkaloid congener. Alper K.R., Glick S.D. Ibogaine: Proceedings of an Interdisciplinary Conference. 2000;Academic Press, New York. in press.
8. Ikemoto S., Panksepp J. The role of nucleus accumbens dopamine in motivated behavior: a unifying interpretation with special reference to reward-seeking. Brain Res. Rev. 31:1999;6-41.
9. Jongen-Relo A.L., Groenewegen H.J., Voorn P. Evidence for a multi-compartmental histochemical organization of the nucleus accumbens in the rat. J. Comp. Neurol. 337:1993;267-276.
10. Kalivas P.W., Stewart J. Dopamine transmission in the initiation and expression of drug- and stress-induced sensitization of motor activity. Brain Res. Rev. 16:1991;223-244.
11. Kalivas P.W., Duffy P., DuMars L.A., Skinner C. Behavioral and neurochemical effects of acute and daily cocaine administration in rats. J. Pharmacol. Exp. Ther. 245:1988;485-492.
12. Kalivas P.W., Pierce R.C., Cornish J., Sorg B.A. A role for sensitization in craving and relapse in cocaine addiction. J. Psychopharmacol. 12:1993;49-53.
13. Maisonneuve I.M., Glick S.D. Interactions between ibogaine and cocaine in rats: in vivo microdialysis and motor behavior. Eur. J. Pharmacol. 212:1992;263-266.
14. Robinson T.E., Berridge K.C. The neural basis of drug craving: an incentive-sensitization theory of drug addiction. Brain Res. Rev. 18:1993;247-291.
15. Sheppard S.G. A preliminary investigation of ibogaine: case reports and recommendations for further study. J. Subst. Abuse Treat. 11:1994;379-385.
16. Sokolowski J.D., Salamone J.D. The role of accumbens dopamine in lever pressing and response allocation: effects of 6-OHDA injected into core and dorsomedial shell. Pharmacol. Biochem. Behav. 59:1998;557-566.
17. Szumlinski K.K., Maisonneuve I.M., Glick S.D. Ibogaine enhances the expression of cocaine-induced locomotor sensitization in chronic cocaine-treated animals. Pharmacol. Biochem. Behav. 63:1999;457-464.
18. Szumlinski K.K., Maisonneuve I.M., Glick S.D. Pretreatment with the putative anti-addictive drug, ibogaine, increases the potency of cocaine to elicit locomotor responding: a study with acute and chronic cocaine-treated rats. Psychopharmacology. 145:1999;227-233.
19. Szumlinski K.K., Maisonneuve I.M., Glick S.D. Iboga agents enhance the expression of cocaine-induced stereotypy in acute and chronic cocaine-treated rats. Behav. Pharmacol. 10(Suppl. 1):1999;S92.
20. Szumlinski K.K., Balogun M.Y., Maisonneuve I.M., Glick S.D. Interactions between iboga agents and methamphetamine sensitization: studies of locomotion and stereotypy in rats. Psychopharmacology. 2000;. in press.
21. Szumlinski K.K., Maisonneuve I.M., Glick S.D. The potential anti-addictive agent, 18-methoxycoronaridine (18-MC) blocks the sensitized dopamine and locomotor responses produced by repeated morphine treatment. Brain Res. 864:2000;13-23.
22. Szumlinski K.K., Maisonneuve I.M., Glick S.D. Iboga interactions with psychomotor stimulants: panacea in the paradox? Toxicon. 2000;. in press.
23. Szumlinski K.K., McCafferty C.A., Maisonneuve I.M., Glick S.D. Interactions between 18-methoxycoronaridine (18-mc) and cocaine: dissociation of behavioural and neurochemical sensitization. Brain Res. 2000;. in press.